SCHEMBL6003228

SCHEMBL6003228

c1ccc(C(OC2CCCC[N]2)c2ccccc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 3/20 0.42
SLC6A2 P23975 3/20 0.42
CYP2D6 P10635 3/20 0.42
CHRM2 P08172 2/20 0.42
ADRA2A P08913 2/20 0.42
CHRM1 P11229 2/20 0.42
DRD1 P21728 2/20 0.42
ADRA1A P35348 2/20 0.42
OPRM1 P35372 2/20 0.42
SLC6A3 Q01959 2/20 0.42
KCNH2 Q12809 2/20 0.42
HTR1A P08908 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
DRD2 P14416 2/20 0.41
MAPK1 P28482 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
CHRM3 P20309 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5859620 0.83 IDO1 (0.36) DRD3SLC6A2CYP2D6CHRM2ADRA2A
SCHEMBL9021303 0.77 IDO1 (0.36) CYP2D6HRH1SIGMAR1IDO1MEN1
SCHEMBL1828238 0.73 HRH1 (0.40) SLC6A2SLC6A3SLC6A4HRH1LMNA
SCHEMBL10727267 0.72 DRD3 (0.62) DRD3SLC6A2CYP2D6CHRM2ADRA2A
SCHEMBL11070013 0.71 HRH1 (0.39) SLC6A2SLC6A3SLC6A4HRH1IDO1
SCHEMBL9439904 0.70 HTT (0.44) SLC6A3HTT
SCHEMBL8643817 0.69 DRD3 (0.59) DRD3SLC6A2CYP2D6CHRM2ADRA2A
SCHEMBL447548 0.69 PSEN1 (0.39) OPRM1HRH3MAPK1SIGMAR1MEN1
SCHEMBL2202292 0.68 GAA (0.37) CYP2D6SIGMAR1IDO1MAPTMEN1
SCHEMBL2094948 0.68 SLC6A3 (0.41) DRD3SLC6A2CYP2D6CHRM2ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed